A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Slovenia- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Slovenia92 clinical trials in Ljubljana, Slovenia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Slovenia
Slovenia
Slovenia
Slovenia
Slovenia
Slovenia
Slovenia
Slovenia
Slovenia
Slovenia
Slovenia
SloveniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Sjögren's Syndrome and inflammatory bowel conditions, including studies evaluating novel therapeutic approaches for Crohn's Disease and Ulcerative Colitis.
Multiple studies investigating long-term effectiveness and patient outcomes in chronic inflammatory conditions.
Comprehensive studies addressing cardiovascular disease and related conditions, including research on lipoprotein management and cardiac inflammation treatments.
Focus on preventive measures and innovative therapeutic approaches for various cardiac conditions.
Advanced research in cancer treatment, including studies on breast cancer, melanoma, and various blood cancers.
Emphasis on personalized treatment approaches and improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.